HealthAid Limited and HealthAid America Inc.

Finvos is pleased to announce that it has advised the shareholders of HealthAid Limited and HealthAid America Inc. on the sale of the business to PK Consumer Health, a portfolio company of Avista Healthcare Partners and Damier Group.

This transaction represents the second add-on acquisition completed by PK Consumer Health since Avista and Damier’s investment in the platform in November 2025 and marks an important milestone in its strategy to build a leading “retail-first” VMS platform, bringing together strong local champions across Europe.

Headquartered in Harrow, HealthAid Limited is widely recognized as a high-quality vitamins, minerals and supplements (VMS) brand trusted by thousands of independent pharmacies globally. The company offers a comprehensive portfolio of VMS products spanning a wide range of categories and galenic formats, supported by a strong service-led model tailored to the independent pharmacy channel. In addition to its direct operations in the United Kingdom and the United States, HealthAid operates in more than 50 countries across Europe and international markets through a long-standing network of distribution partners, many of whom have worked with the company for over three decades.

The acquisition of HealthAid represents the next step in PK Consumer Health’s strategy to become a leading player in the European “retail-first” VMS market. Following the transaction, the platform is expected to approach €200 million in revenue while continuing to deliver strong double-digit organic growth. PK Consumer Health also plans to further strengthen its management structure, unlock operational synergies and invest in its brand portfolio to support the next phase of expansion. Alongside organic growth initiatives, the group will continue to actively pursue M&A opportunities across Europe.

Finvos acted as exclusive financial advisor to the shareholders of HealthAid Limited and HealthAid America Inc. in connection with this transaction.